Global Tinea Versicolor treatment Market Expected to Reach XX Million by 2025

2018-03-12 13:57:34

According to a new report published by Reports Monitor titled, “Tinea Versicolor treatment Market by Diagnosis, by Treatment, and by End User: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the tinea versicolor treatment market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. North America dominates the Tinea Versicolor treatment market, in terms of value, and is expected to maintain this trend throughout the forecast period. 

An advanced diagnostic technique in early phase of the disease along with wide options for preventive measure and immediate cure drives the market for further growth.

Get a Sample PDF Report @

Approval of new antifungal medicines and rising healthcare infrastructure development in developing countries are some of the factors opens untapped market and drives the growth.
Increasing awareness of the disease, increasing prevalence of tinea versicolor, advanced diagnosis and treatment options are led to generate more demand for the treatment.


• Physical examination dominates the diagnosis segment as it is convenient method of diagnosis for patient as well as doctors.
• Topical anti-fungal product accounts for largest share in terms of the revenue due to easy patient compliance.
• Dermatology hospitals and clinics are major contributor to the tinea versicolor treatment market.
• North America is a top contributor in the market followed by Europe region.  

The major companies profiled in the report include Novartis AG, Galderma S.A, Astellas Pharma US, Inc., Enzon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Taro Pharmaceutical Industries Ltd., Enzon Pharmaceuticals, Inc., Gilead, Valeant and others.

About Us:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Mr. Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Related Press Releases